Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 10:04AM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.86 Insider Own9.37% Shs Outstand48.09M Perf Week-9.37%
Market Cap401.93M Forward P/E39.58 EPS next Y0.21 Insider Trans48.97% Shs Float44.07M Perf Month-8.06%
Income-44.77M PEG- EPS next Q-0.21 Inst Own102.01% Short Float13.35% Perf Quarter-12.07%
Sales61.51M P/S6.53 EPS this Y55.10% Inst Trans-0.40% Short Ratio14.65 Perf Half Y-21.29%
Book/sh4.22 P/B1.96 EPS next Y146.50% ROA-9.84% Short Interest5.89M Perf Year-25.27%
Cash/sh2.06 P/C4.02 EPS next 5Y- ROE-15.56% 52W Range8.14 - 11.71 Perf YTD-26.47%
Dividend Est.- P/FCF- EPS past 5Y24.22% ROI-18.00% 52W High-29.42% Beta0.23
Dividend TTM- Quick Ratio5.74 Sales past 5Y0.23% Gross Margin90.36% 52W Low1.54% ATR (14)0.40
Dividend Ex-Date- Current Ratio5.74 EPS Y/Y TTM75.98% Oper. Margin-66.92% RSI (14)34.18 Volatility4.87% 4.65%
Employees99 Debt/Eq0.23 Sales Y/Y TTM26.65% Profit Margin-72.78% Recom1.80 Target Price15.40
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q31.17% Payout- Rel Volume0.31 Prev Close8.41
Sales Surprise3.87% EPS Surprise4.95% Sales Q/Q39.22% EarningsMay 13 AMC Avg Volume401.67K Price8.27
SMA20-10.07% SMA50-10.05% SMA200-13.47% Trades Volume16,618 Change-1.72%
Date Action Analyst Rating Change Price Target Change
Apr-12-24Initiated BTIG Research Buy $21
Jan-08-24Downgrade Evercore ISI Outperform → In-line
May-23-22Initiated SVB Leerink Outperform $12
Nov-05-21Upgrade JP Morgan Underweight → Neutral $12
Sep-15-21Downgrade JP Morgan Overweight → Underweight $7
Aug-25-21Downgrade Morgan Stanley Overweight → Underweight $27 → $14
Aug-24-21Downgrade Cowen Outperform → Market Perform $42 → $14
Oct-14-20Upgrade Morgan Stanley Equal-Weight → Overweight $32
Jul-07-20Initiated JP Morgan Overweight $29
Jun-15-20Initiated Morgan Stanley Equal-Weight $30
May-15-24 03:56PM
May-14-24 12:06PM
May-13-24 08:54PM
04:05PM Loading…
May-09-24 06:00AM
Apr-29-24 06:00AM
Apr-15-24 02:19PM
Apr-10-24 06:00AM
Mar-27-24 11:30AM
Mar-12-24 03:59PM
Feb-28-24 10:35AM
Feb-27-24 11:47AM
05:25PM Loading…
Feb-26-24 05:25PM
Feb-22-24 06:00AM
Feb-14-24 06:00AM
Jan-12-24 09:35AM
Jan-05-24 06:00AM
Dec-24-23 01:08PM
Dec-21-23 05:00PM
Dec-18-23 06:00AM
Dec-07-23 11:30AM
Nov-22-23 09:14AM
Nov-16-23 06:00AM
Nov-15-23 06:00AM
Nov-13-23 08:00AM
02:10PM Loading…
Nov-08-23 02:10PM
Nov-07-23 06:09PM
Oct-19-23 06:00AM
Sep-06-23 11:30AM
Aug-31-23 05:55PM
Aug-29-23 06:00AM
Aug-28-23 06:05AM
Aug-09-23 06:25AM
Aug-08-23 09:54AM
Aug-07-23 05:25PM
Aug-01-23 10:00AM
Jul-24-23 06:00AM
Jul-03-23 09:00AM
Jun-08-23 11:14AM
Jun-07-23 11:30AM
May-18-23 01:50PM
May-11-23 03:41PM
May-10-23 11:34AM
May-09-23 06:00PM
May-08-23 05:55PM
May-04-23 10:00AM
May-01-23 10:01AM
Apr-24-23 06:00AM
Apr-19-23 02:42PM
Apr-17-23 07:47AM
Apr-14-23 04:23AM
Apr-11-23 04:05PM
Apr-10-23 06:00AM
Mar-31-23 12:41PM
Mar-30-23 05:22PM
Mar-29-23 11:30AM
Mar-10-23 06:56AM
Mar-08-23 02:50PM
Mar-02-23 06:00AM
Feb-28-23 02:17PM
Feb-27-23 06:15PM
Feb-23-23 07:46AM
Feb-21-23 06:00AM
Feb-16-23 10:01AM
Feb-15-23 10:00AM
Feb-09-23 06:00AM
Jan-09-23 06:00AM
Dec-25-22 09:39AM
Dec-07-22 11:30AM
Nov-22-22 04:15PM
Nov-18-22 06:00AM
Nov-11-22 08:20AM
Nov-08-22 08:34AM
Nov-07-22 05:45PM
Nov-02-22 04:30PM
Oct-31-22 06:00AM
Oct-27-22 10:02AM
Oct-26-22 10:02AM
Oct-25-22 06:00AM
Sep-28-22 06:00AM
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Samaha Eli10% OwnerMay 01 '24Buy8.751,499,12413,117,3358,511,350May 03 04:19 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 22 '24Sale8.711,25410,922311,733Feb 22 08:04 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSNov 21 '23Sale10.291,37814,180331,206Nov 22 06:07 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 14 '23Sale10.222,48225,366346,839Nov 16 06:16 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTOct 16 '23Sale9.032,48222,412334,321Oct 18 06:54 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTSep 14 '23Sale9.892,48224,547336,803Sep 18 06:08 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSAug 22 '23Sale9.471,80717,112340,566Aug 24 06:05 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTAug 11 '23Sale9.992,32223,197349,746Aug 15 06:09 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTJul 14 '23Sale9.842,32222,848352,068Jul 18 06:14 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTJun 14 '23Sale10.692,32224,822354,390Jun 16 06:14 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSJun 08 '23Sale11.131,79019,923352,833Jun 12 06:08 PM